Alidya

Alidya by Marllor Biomedical SRL is the first injectable solution for the treatment of cellulite based on amino acids and other active ingredients. This mesotherapy treatment is a minimally invasive, non-surgical procedure designed for the effective treatment and prevention of orange-peel skin, which is most common among women. The active ingredients in Alidya contribute to activating several fundamental mechanisms responsible for cellulite formation, making it ideal for correcting skin dimples and surface irregularities. Additionally, the injectable solution can be used to improve skin appearance post-liposuction or as a follow-up treatment after intralipotherapy to correct adipose tissue alterations. Alidya is the first injectable product specifically designed for the prevention and treatment of gynoid lipodystrophy (cellulite). Its unique formulation sets it apart from other cellulite treatments by targeting deeper layers of the skin. Moreover, it adapts better to the biological environment, whether applied to superficial or deeper subdermal areas. The efficacy of Alidya is activated through solubilization and the removal of extracellular toxic elements that contribute to cellulite formation. Additionally, it helps restore normal cellular homeostasis, improving areas prone to cellulite. Alidya aids in dissolving fat responsible for orange-peel skin while softening fibrous tissues to achieve a smoother skin texture. It is ideal for post-liposuction skin correction and other fat-reducing procedures, such as intralipotherapy, but can also be applied to any emerging cellulite-prone areas. This minimally invasive, non-surgical treatment enhances skin structure, delivering smoother, firmer, and more even-toned skin. For optimal results, Alidya should be administered weekly using mesotherapy techniques on areas affected by gynoid lipodystrophy (cellulite). On average, the treatment requires a minimum of 7 sessions per target area, with a maximum of 12 sessions recommended.